Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies

被引:0
|
作者
Michael Rainone
Tanya Siddiqi
机构
[1] City of Hope,Department of Hematology and Medical Oncology
[2] City of Hope,Department of Hematology & Hematopoietic Cell Transplantation
来源
Current Hematologic Malignancy Reports | 2022年 / 17卷
关键词
Chronic lymphocytic leukemia; Small lymphocytic lymphoma; Ibrutinib; Acalabrutinib; Venetoclax; Chimeric antigen receptor (CAR) T cell;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:39 / 45
页数:6
相关论文
共 50 条
  • [21] Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections
    Hilal, Talal
    Gea-Banacloche, Juan C.
    Leis, Jose F.
    BLOOD REVIEWS, 2018, 32 (05) : 387 - 399
  • [22] Venetoclax Management and care for patients with relapsed or refractory chronic lymphocytic leukemia
    Paradis, Heather Brumbaugh
    Alter, Debbie
    Lterandi, Diane
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (05) : 604 - 610
  • [23] Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance
    St-Pierre, Frederique
    Ma, Shuo
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2022, 12 : 81 - 98
  • [24] Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma
    Izutsu, Koji
    Yamamoto, Kazuhito
    Kato, Koji
    Ishikawa, Takayuki
    Fukuhara, Noriko
    Terui, Yasuhito
    Choi, Ilseung
    Humphrey, Kathryn
    Kim, Su Young
    Okubo, Sumiko
    Ogawa, Natsumi
    Nishimura, Yasuko
    Salem, Ahmed Hamed
    Maruyama, Dai
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 370 - 380
  • [25] Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis
    Xu, Wei
    Yang, Shenmiao
    Zhou, Keshu
    Pan, Ling
    Li, Zengjun
    Gao, Sujun
    Zhou, Daobin
    Hu, Jianda
    Feng, Ru
    Huang, Haiwen
    Wang, Tingyu
    Li, Dengju
    Ji, Meng
    Guo, Haiyi
    Zhao, Xia
    Wu, Binghao
    Yu, Yiling
    Wang, Yu
    Huang, Jane
    Novotny, William
    Li, Jianyong
    LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 712 - 716
  • [26] Zanubrutinib Monotherapy for Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies
    Xu, Wei
    Yang, Shenmiao
    Tam, Constantine S.
    Seymour, John F.
    Zhou, Keshu
    Opat, Stephen
    Qiu, Lugui
    Sun, Mingyuan
    Wang, Tingyu
    Trotman, Judith
    Pan, Ling
    Gao, Sujun
    Zhou, Jianfeng
    Zhou, Daobin
    Zhu, Jun
    Song, Yuqin
    Hu, Jianda
    Feng, Ru
    Huang, Haiwen
    Su, Dan
    Shi, Miao
    Li, Jianyong
    ADVANCES IN THERAPY, 2022, 39 (09) : 4250 - 4265
  • [27] The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia
    Nair, Kruti Sheth
    Cheson, Bruce
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (02) : 69 - 84
  • [28] Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma
    Koji Izutsu
    Kazuhito Yamamoto
    Koji Kato
    Takayuki Ishikawa
    Noriko Fukuhara
    Yasuhito Terui
    Ilseung Choi
    Kathryn Humphrey
    Su Young Kim
    Sumiko Okubo
    Natsumi Ogawa
    Yasuko Nishimura
    Ahmed Hamed Salem
    Dai Maruyama
    International Journal of Hematology, 2021, 113 : 370 - 380
  • [29] Small Lymphocytic Lymphoma and Chronic Lymphocytic Leukemia Are They the Same Disease?
    Santos, Fabio P. S.
    O'Brien, Susan
    CANCER JOURNAL, 2012, 18 (05) : 396 - 403
  • [30] Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia in a Pelvic Myelolipoma
    Gheith, Shereen
    Boulay, Richard
    Cornfield, Dennis
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2009, 2 (01): : 95 - 98